MedTrace Logo

Cost Utility Analysis in Recurrent Ovarian Cancer

NCT00813254 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2012-04-19

No results posted yet for this study

Summary

The goal of this research study is to learn about the quality of life and sexual functioning of women with platinum-resistant ovarian cancer as they receive other treatments for the disease.

Researchers will study the costs for chemotherapy treatments, other medical expenses, and treatment-related expenses that are not medical. Researchers will also review any symptoms these patients may experience related to the cancer or treatment.

In addition, researchers want to learn if and how these patients' caregivers feel the status of these patients' health may have affected the caregivers' productivity at work and at home.

Conditions

Interventions

BEHAVIORAL

Questionnaire

Questionnaires 1 - 5 will be completed on Day 1 of study as a Baseline.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Michael M Frumovitz, MD · M.D. Anderson Cancer Center

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00813254 on ClinicalTrials.gov